Research Article
The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy
Table 3
Discussed CAM use with CAM or conventional provider (
).
| Supplement | Used during chemo/radiation | Discussed with | CAM provider | Conventional provider | | (%) | (%) |
| Antioxidants | Alpha-lipoic acid | 11 | 6 (54.5) | 2 (18.2) | Beta carotene | 5 | 1 (20.0) | 1 (20.0) | CoQ10 | 27 | 15 (55.5) | 4 (14.8) | Glutathione | 5 | 3 (60.0) | 1 (20.0) | Grape seed extract | 3 | 1 (33.3) | 0 (0.0) | Green tea | 60 | 20 (33.3) | 4 (6.7) | Lycopene | 1 | 1 (100.0) | 0 (0.0) | Melatonin | 44 | 29 (65.9) | 7 (15.9) | Pycnogenol | 0 | 0 (0.0) | 0 (0.0) | Resveratrol | 3 | 1 (33.3) | 1 (33.3) | Selenium | 7 | 3 (42.9) | 1 (14.3) | Turmeric | 26 | 14 (53.8) | 2 (7.7) | Vitamin A | 24 | 9 (37.5) | 5 (20.8) | Vitamin C | 40 | 13 (32.5) | 8 (20.0) | Vitamin E | 37 | 13 (35.1) | 10 (27.0) |
| Any antioxidant | 129 | 54 (41.9) | 32 (24.8) |
| CYP activity | Bitter orange | 1 | 0 (0.0) | 0 (0.0) | Black cohosh | 5 | 2 (40.0) | 2 (40.0) | Dandelion | 4 | 2 (50.0) | 0 (0.0) | Devil’s claw | 0 | 0 (0.0) | 0 (0.0) | DHEA | 1 | 1 (100.0) | 0 (0.0) | Echinacea | 4 | 2 (50.0) | 0 (0.0) | Feverfew | 0 | 0 (0.0) | 0 (0.0) | Garlic | 29 | 6 (20.7) | 0 (0.0) | Genistein | 2 | 1 (50.0) | 0 (0.0) | Ginkgo biloba | 2 | 1 (50.0) | 1 (50.0) | Goldenseal | 0 | 0 (0.0) | 0 (0.0) | Grapefruit juice | 2 | 1 (50.0) | 0 (0.0) | Green tea | 60 | 20 (33.3) | 4 (6.7) | Guggul tree | 0 | 0 (0.0) | 0 (0.0) | Kava kava | 1 | 1 (100.0) | 0 (0.0) | Licorice | 7 | 4 (57.1) | 0 (0.0) | Milk thistle | 8 | 3 (37.5) | 1 (12.5) | Peppermint oil | 4 | 1 (25.0) | 1 (25.0) | Pycnogenol | 0 | 0 (0.0) | 0 (0.0) | Quercetin | 8 | 6 (75.0) | 2 (25.0) | Red clover | 0 | 0 (0.0) | 0 (0.0) | Resveratrol | 3 | 1 (33.3) | 1 (33.3) | Schisandra | 0 | 0 (0.0) | 0 (0.0) | St. John’s Wort | 2 | 0 (0.0) | 0 (0.0) | Valerian | 1 | 0 (0.0) | 0 (0.0) | Vitamin E | 37 | 13 (35.1) | 10 (27.0) |
| Any CYP | 109 | 38 (34.9) | 18 (16.5) |
| Any of the above | 143 | 60 (42.0) | 34 (23.8) |
|
|